Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Movig

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|March 4, 2000
Analysis of low concentration sufentanil citrate/bupivacaine hydrochloride admixtures, using solid phase extraction followed by high-performance liquid chromatographyK L Movig, M C Langen, A C Egberts
The Annals of Pharmacotherapy|June 22, 2000
Selective prescribing of spasmolyticsK L Movig, A C Egberts, A W Lenderink, et al.
Journal of the American Geriatrics Society|February 24, 2001
Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practiceK L Movig, A C Egberts, A W Lenderink, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical and Biomedical Analysis|March 4, 2000
Analysis of low concentration sufentanil citrate/bupivacaine hydrochloride admixtures, using solid phase extraction followed by high-performance liquid chromatographyK L Movig, M C Langen, A C Egberts
The Annals of Pharmacotherapy|June 22, 2000
Selective prescribing of spasmolyticsK L Movig, A C Egberts, A W Lenderink, et al.
Journal of the American Geriatrics Society|February 24, 2001
Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practiceK L Movig, A C Egberts, A W Lenderink, et al.
Pageof 1